Credit: Penn Medicine
Penn Medicine and Children’s Hospital of Philadelphia (CHOP), who together pioneered research and development of the world’s first personalized cellular therapy for cancer — CAR T cell therapy — have announced plans with Costa Rica’s CCSS, or the Caja Costarricense de Seguro Social (Social Security Program), to facilitate CAR T research in Costa Rica. Two Memoranda of Understanding were announced during a ceremony attended by First Lady Jill Biden on Sunday, May 22, at the National Children’s Hospital in San Jose, Costa Rica.